These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].
    Author: Odegaard S, Busch D.
    Journal: Z Gastroenterol; 1989 Feb; 27(2):91-3. PubMed ID: 2658394.
    Abstract:
    During the therapy of fatty liver (resp. fatty liver hepatitis) the additional application of Hepavis besides the prohibition of alcohol does not have any advantages in comparison to an additional application of a placebo. So the significant decrease of the fat content of the liver under those circumstances seems to be only the consequence of lacking alcohol consume, but not a specific effect of Hepavis. Consequently the treatment of alcoholtoxic fatty liver can be no other than to avoid alcohol, one of the most important causes of illness nowadays.
    [Abstract] [Full Text] [Related] [New Search]